The impact of nature of surgery on the relevance of outcome measures I read with interest the article by Vijay et al 1 on the effect of continuing or withholding angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers before surgery. The audit shows no difference in the measured outcomes either way. Audits have their limitations and these have been discussed in detail by the authors. However, I am intrigued by the fact that the data from cardiac and other non-cardiac surgical procedures have been integrated in a single audit with an aim to compare and analyse metaraminol use, intraoperative fluids and blood pressure. The mode of blood pressure monitoring, surgical indication, haemodynamic goals, use of other inotropes and cardiopulmonary bypass make cardiac surgery very different to the other procedures. In terms of the method of blood pressure monitoring, noninvasive systolic blood pressure can overestimate invasive arterial blood pressure (IAP) during hypotension and therefore has a lower sensitivity to detect acute kidney injury compared to systolic IAP, whereas mean arterial pressures (MAP) are more comparable when procedures involving different methods of monitoring are analysed 2 . Moreover, significance of the lowest systolic blood pressure and its relation to adverse outcomes is uncertain as the end-organ tolerance to a certain degree of hypotension depends on the autoregulatory threshold of that individual 3 . Percentage decrease from baseline or variability in blood pressure, whether it be systolic or mean arterial pressure, may be more relevant to postoperative complications than an absolute value for the systolic blood pressure with no mention of duration. As most of the references the authors cite relate to cardiac surgery, perhaps an exclusive audit of cardiac surgery patients may have made the conclusions more applicable to practice.
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